Jaguar Health secures $40M equity line and closes $2M preferred stock financing

Filed June 11, 2026 · Period ending June 8, 2026 · ~2 min read

Key Changes

• high

  Company entered $40M equity line of credit with institutional investor, allowing stock sales in tranches at $1.10 floor price. Investor ownership capped at 4.99%; company will issue $800K in commitment shares when registration becomes effective.

  Item 1.01 - ELOC Agreement verify on EDGAR →
• high

  Stockholders approved both financings on June 8, removing 19.99% cap on share issuance. This enables full access to $40M facility and unlimited preferred stock conversion, potentially causing significant dilution to existing common shareholders.

  Item 5.03 - Stockholder Approval verify on EDGAR →
• high

  Closed $2M private placement of 240 shares Series P Preferred Stock with 8% annual dividend. Company must redeem at least 10% of preferred shares whenever it draws on the equity line, payable in cash or common stock.

  Item 3.02 - Preferred Stock verify on EDGAR →